Galectin Therapeutics Inc. (GALT) Social Stream



Galectin Therapeutics Inc. (GALT): $1.25

-0.04 (-3.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GALT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 458

in industry

GALECTIN THERAPEUTICS INC (GALT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GALT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-01 1 $14 $14 $14 $1.29 985.27%
2022-11-15 1 $11 $11 $11 $1.29 752.71%

Price Target Last Issued November 15, 2022

The Trend in the Analyst Price Target


Over the past 15 months, GALT's average price target has gone down $3.

GALT reports an average of 673.14% for its upside potential over the past 33 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-01 1 14 14 14 1.58 786.08%
2022-05-17 1 11 11 11 1.35 714.81%
2022-08-16 1 11 11 11 2.18 404.59%
2022-11-15 1 11 11 11 1.24 787.1%

GALT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 52 weeks, GALT's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GALT as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's number of analysts covering the stock is higher than nearly none of them.
  • To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's variance in analysts' estimates is lower than just about 100% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, GALECTIN THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 174.91% of them.
  • GALECTIN THERAPEUTICS INC's average analyst price target is higher than 46.41% of Healthcare stocks.

In the Pharmaceutical Products industry, ORIC, AKUS, and PNT are the three stocks most similar to GALECTIN THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for GALT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8977 seconds.